236 related articles for article (PubMed ID: 10440132)
1. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
Sugimoto H; Shikata K; Wada J; Horiuchi S; Makino H
Diabetologia; 1999 Jul; 42(7):878-86. PubMed ID: 10440132
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
[TBL] [Abstract][Full Text] [Related]
4. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite plays a key role in glomerular lesions in diabetic rats.
Xiao H; Li Y; Qi J; Wang H; Liu K
J Nephrol; 2009; 22(6):800-8. PubMed ID: 19967660
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of a novel inhibitor of advanced glycation.
Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
[TBL] [Abstract][Full Text] [Related]
7. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase (iNOS) expression is increased in lipopolysaccharide (LPS)-stimulated diabetic rat glomeruli: effect of ACE inhibitor and angiotensin II receptor blocker.
Lee HY; Noh HJ; Gang JG; Xu ZG; Jeong HJ; Kang SW; Choi KH; Han DS
Yonsei Med J; 2002 Apr; 43(2):183-92. PubMed ID: 11971212
[TBL] [Abstract][Full Text] [Related]
9. Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
Kamijo H; Higuchi M; Hora K
Nephron Physiol; 2006; 104(1):p12-22. PubMed ID: 16691035
[TBL] [Abstract][Full Text] [Related]
10. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
[TBL] [Abstract][Full Text] [Related]
12. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.
Yang CW; Yu CC; Ko YC; Huang CC
Clin Exp Immunol; 1998 Aug; 113(2):258-64. PubMed ID: 9717976
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
[TBL] [Abstract][Full Text] [Related]
14. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
Roufail E; Soulis T; Boel E; Cooper ME; Rees S
Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
[TBL] [Abstract][Full Text] [Related]
15. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
[TBL] [Abstract][Full Text] [Related]
16. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats.
Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H
Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764
[TBL] [Abstract][Full Text] [Related]
17. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.
Cameron NE; Cotter MA
Metabolism; 1996 Sep; 45(9):1147-52. PubMed ID: 8781303
[TBL] [Abstract][Full Text] [Related]
18. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
Schwartz D; Schwartz IF; Blantz RC
J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia in the diabetic kidney is independent of advanced glycation end-products.
Nordquist L; Liss P; Fasching A; Hansell P; Palm F
Adv Exp Med Biol; 2013; 765():185-193. PubMed ID: 22879032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
